Results 181 to 190 of about 1,084,291 (346)

Risk Sharing Between Competing Health Plans And Sponsors

open access: green, 2001
Erik M. van Barneveld   +2 more
openalex   +1 more source

Reconfigurable Nucleic Acid Nanoparticles with Therapeutic RNAi Responses to Intracellular Disease Markers

open access: yesAdvanced Functional Materials, EarlyView.
Many known diseases arise from dysregulated gene expression, and differentially expressed genes can serve as biomarkers to distinguish diseased cells from healthy tissues. In this study, reconfigurable nucleic acid nanoparticles (recNANPs) are introduced that can detect overexpressed cancer biomarkers and subsequently release RNAi inducers to silence ...
Yelixza I. Avila   +7 more
wiley   +1 more source

Disease trajectory and competing risks of patients with cirrhosis in the US. [PDF]

open access: yesPLoS One
Mohammadi M   +15 more
europepmc   +1 more source

Bivariate copula regression models for semi-competing risks. [PDF]

open access: yesStat Methods Med Res, 2023
Wei Y, Wojtyś M, Sorrell L, Rowe P.
europepmc   +1 more source

Tunable Synthetic Hydrogel Modulates Hepatic Lineage Specification of Human Liver Organoid

open access: yesAdvanced Functional Materials, EarlyView.
In this study, a synthetic hydrogel is reported that supports the formation of hiPSC‐derived human liver organoids (HLOs). Hepatic lineage specification can be modulated via conjugation of RGD peptide to hydrogel: RGD‐conjugated hydrogels promote cholangiocyte differentiation, whereas RGD‐free hydrogels favor hepatocyte commitment of HLO cells.
Lei Wang   +16 more
wiley   +1 more source

Home - About - Disclaimer - Privacy